about
Th17 Cell Plasticity and Functions in Cancer ImmunityImproving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer VaccinationImmunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple MyelomaExposure of Human CD4 T Cells to IL-12 Results in Enhanced TCR-Induced Cytokine Production, Altered TCR Signaling, and Increased Oxidative Metabolism.A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with Candida skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3.Participation of Tumor-Associated Myeloid Cells in Progression of Amelanotic Melanoma (RMM Tumor Line) in F344 Rats, with Particular Reference to MHC Class II- and CD163-Expressing Cells.Development and Evaluation of Biodegradable Particles Coloaded With Antigen and the Toll-Like Receptor Agonist, Pentaerythritol Lipid A, as a Cancer Vaccine.Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.Dynamic alterations of bone marrow cytokine landscape of myelodysplastic syndromes patients treated with 5-azacytidine.IL-12 protects from psoriasiform skin inflammationInterleukin-12 bypasses common gamma-chain signalling in emergency natural killer cell lymphopoiesis.Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model.LEAPS Vaccine Incorporating HER-2/neu Epitope Elicits Protection That Prevents and Limits Tumor Growth and Spread of Breast Cancer in a Mouse Model.Exploiting cytokines in adoptive T-cell therapy of cancer.Optogenetic Immunomodulation: Shedding Light on Antitumor Immunity.Antimetastatic pectic polysaccharide from Decalepis hamiltonii; galectin-3 inhibition and immune-modulation.Non-viral nucleic acid delivery methods.Increasing the safety and efficacy of chimeric antigen receptor T cell therapy.Mini-review of conventional and hypofractionated radiation therapy combined with immunotherapy for non-small cell lung cancer.Cancer immunotherapy: Breakthrough or "deja vu, all over again"?Tumor growth accelerated by chemotherapy-induced senescent cells is suppressed by treatment with IL-12 producing cellular vaccines.c-Src Suppresses Dendritic Cell Antitumor Activity via T Cell Ig and Mucin Protein-3 Receptor.Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade.Commentary: IL-12-secreting tumor-targeted chimeric antigen receptor T cells: An unaddressed concern on Koneru et al. (2015).Critical roles of conventional dendritic cells in promoting T cell-dependent hepatitis through regulating natural killer T cells.Anti-cancer effects of Ajwa dates (Phoenix dactylifera L.) in diethylnitrosamine induced hepatocellular carcinoma in Wistar ratsInterleukin-12 inhibits pathological neovascularization in mouse model of oxygen-induced retinopathy.Reprogramming of TLR7 signaling enhances antitumor NK and cytotoxic T cell responses.Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients.Intratumoural interleukin 12 gene therapy stimulates the immune system and decreases angiogenesis in dogs with spontaneous cancer.Melanoma treatment with intratumoral electroporation of tavokinogene telseplasmid (pIL-12, tavokinogene telseplasmid).Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers.Synthetic RNA-Based Immunomodulatory Gene Circuits for Cancer Immunotherapy.Two is better than one: advances in pathogen-boosted immunotherapy and adoptive T-cell therapy.Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma.Tissue microenvironment dictates the fate and tumor-suppressive function of type 3 ILCs.Intraocular inflammatory cytokines in patients with neovascular age-related macular degeneration before and after initiation of intravitreal injection of anti-VEGF inhibitor.E pluribus unum: Combining Molecular Strategies to Defeat Head and Neck Cancer.Pro-inflammatory allogeneic DCs promote activation of bystander immune cells and thereby license antigen-specific T-cell responses.
P2860
Q27012901-63F68FA7-64D7-422E-96C1-1AA76F0CA801Q28068378-DDAA6AE6-21C9-4663-880C-40922FC75E41Q28078539-43477C6A-170E-474B-B523-5271C317E680Q35925252-3AAEA389-8219-4E1D-8A8C-11AEE13FAFD4Q36046409-AEA73311-0125-400B-8DB6-AB9ECD2DB0F8Q36110315-6BFEEA08-EC39-4BF6-BA60-029C2C370A56Q36407773-A94AFE4F-948F-4D81-B495-298162881C57Q36642860-68F15C5D-A904-4302-B702-4494CEF57FD7Q36879787-A0D7D043-909D-4026-B7C7-2C1BF5485F39Q37380379-BF0D3F82-436B-40B4-8A53-7453AD0DB004Q37465195-CAF74394-CDD5-4D62-B739-82B88AB26777Q37519452-B329DC48-081E-40E0-AE26-4DA0F3871171Q37706248-57AACEC2-E1F6-472C-81B3-FCACC39A94BAQ37742740-1957BBF1-1387-4FBC-B3BB-4E71F0C77BABQ38525044-176A8378-DDF3-4693-AEBB-E937C5D82478Q38815767-EDCB7763-F607-4B6D-86D2-41AC99838788Q38979750-7176FFD1-8F77-4CD1-8EE2-3946F62D3580Q38980476-9F31AD83-8FC6-4795-B55E-E3A01B072135Q39256918-10617398-D236-4755-89C4-DED2C74EA581Q39321633-22629E7D-6D56-4C09-95C9-205A46DE961EQ39390619-49C0E0BA-632C-43D8-A505-7C2BA27532C2Q39569192-89F52939-376D-4629-983C-E4B071631F88Q39579445-10B1BFE4-5835-41C8-983A-10C6107322F6Q40082476-6B5B649D-44CF-4FA8-AC1C-F7F2C60E166FQ40438508-490FDA2B-E1A8-46FB-B0A8-6D6E3239C4BBQ40454892-45FE2450-0221-4D4B-852D-4E219B9A52F0Q41491468-37A2717A-4B4B-4527-BEE6-15E5B010D3D5Q41906680-1F1CB664-38C5-4E65-8215-CAF987BBB8ABQ42357973-120BF1A2-3863-4DE4-9EEA-9E3BEEA8BB45Q43110773-7113074A-8DB8-430B-B71F-62FE2594CC4BQ45857246-F83E0C2F-D496-4BEE-8DA7-2EBB8075CDA9Q45873521-311560D3-7CAF-46F1-8F83-F0681B54B1BCQ47109220-6B697005-88AD-46E7-9CEB-6E37B40752CCQ47423662-CBBE952C-29AA-4BB4-922B-D83FBC7C4718Q47709474-D3375CAF-2166-43E1-80BA-BDBDC3506FC1Q47739176-2E25086F-ABE1-468D-82AE-F7B567086C05Q48143276-1D6B944C-B5F5-439E-96A9-966D4448A95EQ48216065-737D1638-F3D4-4119-AE2A-37C9C12CBDDEQ50063970-C6E90E0A-5AB3-4924-83C6-1ACB64BD6255Q50535283-70B36BE1-AD14-4C05-A559-1B24EC678363
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
New insights into IL-12-mediated tumor suppression.
@ast
New insights into IL-12-mediated tumor suppression.
@en
New insights into IL-12-mediated tumor suppression.
@nl
type
label
New insights into IL-12-mediated tumor suppression.
@ast
New insights into IL-12-mediated tumor suppression.
@en
New insights into IL-12-mediated tumor suppression.
@nl
prefLabel
New insights into IL-12-mediated tumor suppression.
@ast
New insights into IL-12-mediated tumor suppression.
@en
New insights into IL-12-mediated tumor suppression.
@nl
P2093
P2860
P356
P1476
New insights into IL-12-mediated tumor suppression
@en
P2093
P2860
P2888
P304
P356
10.1038/CDD.2014.134
P577
2014-09-05T00:00:00Z